Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02478710 · ClinicalTrials.gov registry record · Phase 4
Aerosolized Antibiotics in the Treatment of Ventilator Associated Pneumonia
A Phase 4 study, sponsored by Wright State University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 16
- Enrollment target
NCT02478710 is a Phase 4 study that was terminated before completion, run by Wright State University. The registered enrollment target is 16 participants.
The verdict
NCT02478710, a Phase 4 study, was terminated before completion, sponsored by Wright State University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 16 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if administering inhaled antibiotics directly into the lungs in conjunction with intravenous (IV) antibiotics leads to better outcomes and decreased recurrence of ventilator associated pneumonia (VAP) when compared to IV antibiotics alone.
Interventions
- DRUG Aerosolized Placebo
- DRUG Aerosolized Tobramycin or Vancomycin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2015-06 |
| Est. Completion | 2022-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02478710
The ClinicalTrials.gov registry entry for NCT02478710 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wright State University, which has 32 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Aerosolized Placebo is the first listed.
NCT02478710 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02478710 about?
NCT02478710 is a clinical study titled "Aerosolized Antibiotics in the Treatment of Ventilator Associated Pneumonia". The purpose of this study is to determine if administering inhaled antibiotics directly into the lungs in conjunction with intravenous (IV) antibiotics leads to better outcomes and decreased recurrence of ventilator associated pneumonia (VAP) when compared to IV antibiotics alone.
What is the current status of trial NCT02478710?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 16 participants. The study started on 2015-06. Estimated completion is 2022-07.
What interventions are being tested in trial NCT02478710?
The interventions under investigation include: Aerosolized Placebo (DRUG), Aerosolized Tobramycin or Vancomycin (DRUG).
Who is sponsoring clinical trial NCT02478710?
This trial is sponsored by Wright State University, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.